IADR Abstract Archives

The Effect of Cyclodextrin Complexation on Bupivacaine Cytotoxicity in Human Fibroblasts

Objectives: To evaluate the effect of bupivacaine (BUPI) alone or complexed with 2-hydroxypropyl-β-cyclodextrin (BUPI-HPβCD) on release of some pro-inflammatory cytokines and on cell-viability of human fibroblasts (FGH).
Methods: Cells were grown in DMEM medium supplemented with 10% heat-inactivated FBS and 50 µg/mL gentamicin. FGH were exposed to 1 µM, 10 µM and 100 µM of bupivacaine formulations during 6 h. Cell viability were determined by XTT (in %) and live/dead assays. Cytokines (IL-1alpha, IL-6, IL-8, and TNF-alpha) quantification (ng/mL) was performed by ELISA. Kruskal-Wallis and SNK tests were used to compare formulations (alpha=5%).
Results: Table 1 shows the results (median and interquartile deviation). None statistically significant differences were observed among groups regarding IL-1alpha. BUPI, independently of concentration, changed the levels of the other cytokines. BUPI-HPβCD also altered the cytokines levels in comparison to both control and BUPI groups. Both BUPI-HPβCD 1 µM and 10 µM reduced cell viability.
Conclusions: The complexation with HPβCD changed the effect of BUPI on FGH cytokines release. This effect was not dependent on BUPI concentration. HPβCD also increased BUPI toxicity on FGH.
IADR/APR General Session
2016 IADR/APR General Session (Seoul, Korea)
Seoul, Korea
2016
0063
Dental Anesthesiology Research
  • Groppo, Francisco  ( UNICAMP , Piracicaba , Brazil )
  • Ferreira, Luiz  ( UNICAMP , Piracicaba , Brazil )
  • Muniz, Bruno  ( UNICAMP , Piracicaba , Brazil )
  • De Paula, Eneida  ( UNICAMP , Piracicaba , Brazil )
  • Ranali, Jose  ( UNICAMP , Piracicaba , Brazil )
  • Volpato, Maria  ( UNICAMP , Piracicaba , Brazil )
  • Fapesp #2006/00121-9
    NONE
    Oral Session
    Anesthesia, Pain Control & Sedation: Efficacy, Toxicity & Special Care Patients I
    Wednesday, 06/22/2016 , 02:30PM - 04:00PM
    Table 1
      BUPIBUPI-HPβCDKruskal-Wallis
     Control100 µM10 µM1 µM100 µM10 µM1 µMp
    IL-1alpha37.3 (26.2)32.9 (9.4)25.6 (5.7)35.4 (18.1)32.9 (23.4)20.7 (9.6)27.5 (18.4)0.0502
    IL-677 (38.6)319.4 (440.5)464.5 (240.5)298.6 (119.3)129.7 (51.8)223.1 (172.3)208.1 (150.4)< 0.0001
    IL-844.9 (10.1)14.5 (8.3)20.5 (17.4)14.1 (10.8)79.3 (60.7)63.8 (24.3)51.3 (28.1)< 0.0001
    TNF-alpha128.2 (13.2)57.5 (10.8)59.6 (15.7)65.3 (7.1)56.2 (29.2)80.8 (46.4)55.3 (18.4)0.0002
    Cell growth102.4 (14.7)89 (50)98.2 (17.4)99.4 (51.2)104.8 (47.8)58.1 (6.1)62.6 (11.6)< 0.0001